Antiglycation activity of melatonin


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

For the first time, it was found that the hormone melatonin exhibited antiglycation activity in vitro. It was shown that melatonin significantly slowed down the accumulation of fluorescent Schiff adducts formed as a result of BSA modification in the presence of high concentration of fructose. It was noted that, unlike the fructosylation reaction, melatonin did not affect the process of modification of BSA by methylglyoxal. We assume that melatonin is able to inhibit the development of the Maillard reaction but does not affect the process of BSA modification by reactive carbonyls.

作者简介

A. Dontsov

Emanuel Institute of Biochemical Physics

编辑信件的主要联系方式.
Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334

N. Vospelnikova

Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation

Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119992

P. Zack

Emanuel Institute of Biochemical Physics

Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334

M. Ostrovsky

Emanuel Institute of Biochemical Physics

Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2017